Zomedica Corp. (OTCQB: ZOMDF), an animal health company, announced its financial results for the fourth quarter and full year ended December 31, 2025. The company achieved a record revenue of $10.5 million for Q4, marking a 33% increase compared to the same period last year. This growth was driven by a 20% increase in consumables and strong performance from its newly introduced Development Services segment, which contributed $3.1 million in revenue. For the full year, Zomedica reported total revenue of $32 million, reflecting a 17% increase from $27.3 million in 2024. The company maintained a gross margin of 68% and ended the year with $53.3 million in liquidity. CEO Larry Heaton emphasized the significance of surpassing $10 million in quarterly revenue for the first time, highlighting the company's consistent growth and operational efficiency. Zomedica's strategic focus on expanding its product offerings and enhancing its market presence has positioned it well for continued success in the animal healthcare sector.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.